|Articles|April 22, 2020

Next-Generation Biopharmaceutical Development Services

Catalent Biologics is a global leader in biopharmaceutical development services, bringing next-generation therapies to the market.

Catalent Biologics is a global leader in biopharmaceutical development  services, bringing next-generation therapies to the market. Its recent  acquisitions of Paragon Bioservices and MaSTherCell have expanded  its service portfolio to include development and manufacturing of cell  and gene therapies, alongside new biological entities, biosimilars, sterile injectables, and antibody-drug conjugates.

 

 INTERPHEX Booth # 1147

 

Catalent Pharma Solutions
14 Schoolhouse Road Somerset, NJ 08873, USA
solutions@catalent.comwww.catalent.com/biologics
tel. +1.888.765.8846

 


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.